Thermo Fisher Scientific Inc. [TMO] stock prices are up 1.04% to $572.03 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TMO shares have gain 3.47% over the last week, with a monthly amount glided 2.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024. In a post published today on Yahoo Finance, Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. (EST).
From an analyst’s perspective:
Thermo Fisher Scientific Inc. [NYSE: TMO] stock has seen the most recent analyst activity on January 24, 2024, when Barclays downgraded its rating to a Equal Weight and also boosted its price target to $555 from $475. Previously, Bernstein downgraded its rating to Mkt Perform on January 08, 2024. On December 18, 2023, HSBC Securities initiated with a Buy rating and assigned a price target of $610 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $575 on December 13, 2023. KeyBanc Capital Markets downgraded its rating to a Sector Weight. Wells Fargo upgraded its rating to Equal Weight for this stock on October 25, 2023, and upped its price target to $475. In a note dated September 28, 2023, Bernstein initiated an Outperform rating and provided a target price of $603 on this stock.
The stock price of Thermo Fisher Scientific Inc. [TMO] has been fluctuating between $415.60 and $593.17 over the past year. Currently, Wall Street analysts expect the stock to reach $641.39 within the next 12 months. Thermo Fisher Scientific Inc. [NYSE: TMO] shares were valued at $572.03 at the most recent close of the market. An investor can expect a potential return of 12.13% based on the average TMO price forecast.
Analyzing the TMO fundamentals
The Thermo Fisher Scientific Inc. [NYSE:TMO] reported sales of 42.86B for trailing twelve months, representing a drop of -4.93%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 567.03 points at the first support level, and at 562.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 575.02, and for the 2nd resistance point, it is at 578.01.
Ratios To Look Out For
It’s worth pointing out that Thermo Fisher Scientific Inc. [NYSE:TMO]’s Current Ratio is 1.75. Also, the Quick Ratio is 1.39, while the Cash Ratio stands at 0.58. Considering the valuation of this stock, the price to sales ratio is 5.09, the price to book ratio is 4.73 and price to earnings (TTM) ratio is 37.02.
Transactions by insiders
Recent insider trading involved CASPER MARC N, Chairman & CEO, that happened on Feb 15 when 5547.0 shares were sold. Director, Spar Debora L completed a deal on Feb 12 to sell 164.0 shares. Meanwhile, SVP and General Counsel Boxer Michael A sold 14566.0 shares on Feb 07.
